Piper DW, Fenton BH
Intraperitoneal glucose tolerance test (ipGTT) Ten-week-old C57BL/6 J mice (The Jackson Laboratory, Bar Harbor, ME, USA) were administered the indicated drugs (15 nmol/kg) and maintained for 24 h, prior to testing, including a 6-h fasting period immediately before the ipGTT
Polonsky W, Gamble C, Iyer N, Martin M, Hamersky C
Before infusion, mice were relocated to new cages with fresh bedding to ensure that no remnant food pellets remained in the cage
For select patients, lower-dose semaglutide or tirzepatide protocols may be used to support: Appetite regulation Craving reduction Metabolic flexibility Reduced inflammation Longevity and healthy aging Body composition maintenance Microdosing may be appropriate for: Normal weight patients Mildly overweight patients Maintenance patients Metabolically healthy individuals Patients sensitive to side effects Those seeking a gentler approach Our microdosing philosophy focuses on individualized metabolic support rather than aggressive appetite suppression